Kimia Farma (Persero) Overview

  • Year Founded
  • 1816

Year Founded

  • Status
  • Public

  • Employees
  • 9,361

Employees

  • Stock Symbol
  • KAEF

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.02
  • (As of Monday Closing)

Kimia Farma (Persero) General Information

Description

PT Kimia Farma Persero Tbk, formerly PT Kimia Farma Tbk, is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.

Contact Information

Formerly Known As
Kimia Farma, NV Chemicalien Handle Rathkamp & Co.
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Jalan Veteran Number 9 2, RT.2/RW.3
  • Gambir, Kecamatan Gambir, Kota Jakarta Pusat, Daerah Khusus Ibukota
  • Jakarta, 10110
  • Indonesia
Primary Industry
Drug Discovery
Other Industries
Personal Products
Stock Exchange
IDX
Vertical(s)
Corporate Office
  • Jalan Veteran Number 9 2, RT.2/RW.3
  • Gambir, Kecamatan Gambir, Kota Jakarta Pusat, Daerah Khusus Ibukota
  • Jakarta, 10110
  • Indonesia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kimia Farma (Persero) Stock Performance

As of 16-Nov-2026, Kimia Farma (Persero)’s stock price is $0.02. Its current market cap is $118M with 5.57B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.02 $0.02 - $0.05 $118M 5.57B 2.3M

Kimia Farma (Persero) Financials Summary

As of 30-Sep-2026, Kimia Farma (Persero) has a trailing 12-month revenue of $539M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 552,359 639,747 667,861 1,065,763
Revenue 538,631 558,943 625,697 647,089
EBITDA 44,843 37,142 (7,370) (66,785)
Net Income (12,594) (20,299) (53,024) (128,749)
Total Assets 812,710 847,615 912,731 1,065,047
Total Debt 392,727 417,068 443,317 495,254
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kimia Farma (Persero) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kimia Farma (Persero)‘s full profile, request access.

Request a free trial

Kimia Farma (Persero) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
PT Kimia Farma Persero Tbk, formerly PT Kimia Farma Tbk, is an Indonesia-based company engaged in the production and dis
Drug Discovery
Jakarta, Indonesia
9,361 As of 2026

Jakarta, Indonesia
 

Jakarta, Indonesia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kimia Farma (Persero) Competitors (4)

One of Kimia Farma (Persero)’s 4 competitors is Tempo Scan Pacific, a Corporation company based in Jakarta, Indonesia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tempo Scan Pacific Corporation Jakarta, Indonesia
Kalbe Farma Corporation Jakarta, Indonesia
Procter & Gamble Hygiene and Health Care Corporation Mumbai, India
Cipla Corporation Mumbai, India
To view Kimia Farma (Persero)’s complete competitors history, request access »

Kimia Farma (Persero) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kimia Farma (Persero) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kimia Farma (Persero)‘s full profile, request access.

Request a free trial

Kimia Farma (Persero) Acquisitions (3)

Kimia Farma (Persero)’s most recent deal was a Merger/Acquisition with Phapros. The deal was made on 27-Mar-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Phapros 27-Mar-2019 Merger/Acquisition Pharmaceuticals
Al-Dawaa Medical Services 05-Mar-2018 Merger/Acquisition Distributors (Healthcare)
Mandiri Inhealth 02-May-2014 Merger/Acquisition Life and Health Insurance
To view Kimia Farma (Persero)’s complete acquisitions history, request access »

Kimia Farma (Persero) ESG

Risk Overview

Risk Rating

Updated November, 30, 2025

40.28 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Pharmaceuticals

Industry

of 952

Rank

Percentile

Pharmaceuticals

Subindustry

of 438

Rank

Percentile

To view Kimia Farma (Persero)’s complete esg history, request access »

Kimia Farma (Persero) Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Al-Dawaa Medical Services Al-Khobar, Saudi Arabia 1993
Phapros Jakarta, Indonesia 1954

Kimia Farma (Persero) FAQs

  • When was Kimia Farma (Persero) founded?

    Kimia Farma (Persero) was founded in 1816.

  • Where is Kimia Farma (Persero) headquartered?

    Kimia Farma (Persero) is headquartered in Jakarta, Indonesia.

  • What is the size of Kimia Farma (Persero)?

    Kimia Farma (Persero) has 9,361 total employees.

  • What industry is Kimia Farma (Persero) in?

    Kimia Farma (Persero)’s primary industry is Drug Discovery.

  • Is Kimia Farma (Persero) a private or public company?

    Kimia Farma (Persero) is a Public company.

  • What is Kimia Farma (Persero)’s stock symbol?

    The ticker symbol for Kimia Farma (Persero) is KAEF.

  • What is the current stock price of Kimia Farma (Persero)?

    As of 16-Nov-2026 the stock price of Kimia Farma (Persero) is $0.02.

  • What is the current market cap of Kimia Farma (Persero)?

    The current market capitalization of Kimia Farma (Persero) is $118M.

  • What is Kimia Farma (Persero)’s current revenue?

    The trailing twelve month revenue for Kimia Farma (Persero) is $539M.

  • Who are Kimia Farma (Persero)’s competitors?

    Tempo Scan Pacific, Kalbe Farma, Procter & Gamble Hygiene and Health Care, and Cipla are competitors of Kimia Farma (Persero).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process